LXRX

Lexicon Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 0/10
Lexicon Pharmaceuticals sales and earnings growth
LXRX Growth
Good
  • Revenue Y/Y↑ 60.24%
  • EPS Y/Y↑ 77.78%
  • FCF Y/Y↑ 62.27%
Lexicon Pharmaceuticals gross and profit margin trends
LXRX Profitability
Neutral
  • Gross margin ↑ 99.40%
  • EPS margin↓ -101.10%
  • ROIC 5Y↓ -61.68%
Lexicon Pharmaceuticals net debt vs free cash flow
LXRX Risk
Great
  • Debt / Equity↓ 0.5
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -5.0

Lexicon Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗